Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or ...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
14 Jun 2021
Using a novel cervical precancer screening approach to detect HPV in incarcerate...
Dr Kofi Effah, Catholic Hospital, Battor, Ghana
Using a novel cervical precancer screening approach to detect HPV in incarcerated women in Ghana ( Dr Kofi Effah, Catholic Hospital, Battor, Ghana )
14 Jun 2021
Real world evidence on the use of antibody drug conjugates in peripheral T-cell ...
Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Leba...
Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )
14 Jun 2021
Developments in metastatic hormone-sensitive prostate cancer
Prof Karim Fizazi, Prof Alicia Morgans, Prof Neeraj Agarwal and Prof Laura-Maria...
Developments in metastatic hormone-sensitive prostate cancer ( Prof Karim Fizazi, Prof Alicia Morgans, Prof Neeraj Agarwal and Prof Laura-Maria Krabbe )
11 Jun 2021
Primary analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-...
Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA
Primary analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-CML ( Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA )
11 Jun 2021
Marizomib in combination with temozolomide-based radiochemotherapy for newly dia...
Dr Patrick Roth - University Hospital Zurich, Zurich, Switzerland
Marizomib in combination with temozolomide-based radiochemotherapy for newly diagnosed glioblastoma ( Dr Patrick Roth - University Hospital Zurich, Zurich, Switzerland )
11 Jun 2021
Pembrolizumab improves on chemo in MSI-H/dMMR mCRC
Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris, Fran...
Pembrolizumab improves on chemo in MSI-H/dMMR mCRC ( Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris, France )
11 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC ( Dr Christina Baik - University of Washington School of Medicine, Seattle, USA )
11 Jun 2021
PROMISE-GIM6: GnRH agonist use during chemotherapy for early breast cancer to pr...
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
PROMISE-GIM6: GnRH agonist use during chemotherapy for early breast cancer to preserve ovarian function ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
11 Jun 2021
ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in t...
Dr Jeff Sharman - Willamette Valley Cancer Institute, Eugene, USA
ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve CLL - Four-year follow up ( Dr Jeff Sharman - Willamette Valley Cancer Institute, Eugene, USA )
11 Jun 2021
CLL14: Venetoclax plus obinutuzumab in untreated CLL
Dr Othman Al-Sawaf - University Hospital of Cologne, Cologne, Germany
CLL14: Venetoclax plus obinutuzumab in untreated CLL ( Dr Othman Al-Sawaf - University Hospital of Cologne, Cologne, Germany )
11 Jun 2021
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy...
Prof Heather Wakelee - Stanford University, Stanford, USA
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy in resected NSCLC ( Prof Heather Wakelee - Stanford University, Stanford, USA )
11 Jun 2021